Mark E. Tometsko
Impact in
- Molecular Biology top 5%
- Bone Metabolism and Diseases
- Oncology top 5%
- Cytokine Signaling Pathways and Interactions
- Bone health and treatments
Papers in
- Oncology 5
- Cancer Cells and Metastasis 2
- Drug Transport and Resistance Mechanisms 2
- Cytokine Signaling Pathways and Interactions 1
-
- NF-κB Signaling Pathways 1
- Co-authors
- William C. Dougall (8 shared papers)David J. Cosman (4 shared papers)Dirk M. Anderson (3 shared papers)Laurent Galibert (2 shared papers)Eileen R. Roux (1 shared paper)Eugene Maraskovsky (1 shared paper)Robert F. DuBose (1 shared paper)Mark Teepe (1 shared paper)
- Journals
- Journal of Biological Chemistry (4 papers)Cancer Research (3 papers)Clinical & Experimental Metastasis (1 paper)Molecular Pharmaceutics (1 paper)Nature (1 paper)
- Partner nations
- United StatesJapanSpain
In The Last Decade
Mark E. Tometsko
13 papers receiving 3.2k citations
Mark E. Tometsko's Hit Papers
Peers
Comparison fields: 5 of 89
- Molecular Biology 1.8k
- Oncology 537
- Immunology 436
- Cancer Research 258
- Orthopedics and Sports Medicine 109
Countries citing papers authored by Mark E. Tometsko
This map shows the geographic impact of Mark E. Tometsko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Tometsko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Tometsko more than expected).
Fields of papers citing papers by Mark E. Tometsko
This network shows the impact of papers produced by Mark E. Tometsko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Tometsko. The network helps show where Mark E. Tometsko may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark E. Tometsko, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function Hit paper breakdown → | 1997 | 1949 |
| 2 | 1995 | 319 | |
| 3 | 1998 | 292 | |
| 4 | 2002 | 214 | |
| 5 | 2012 | 168 | |
| 6 | 2015 | 118 | |
| 7 | 2004 | 76 | |
| 8 | 2013 | 53 | |
| 9 | 2015 | 43 | |
| 10 | 2016 | 38 | |
| 11 | 2014 | 36 | |
| 12 | 2015 | 28 | |
| 13 | 2011 | 4 |
About Mark E. Tometsko
Mark E. Tometsko is a scholar working on Oncology, Cancer Research, Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pharmacology, having authored 13 papers that have together received 3.3k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (5 papers), Cancer Cells and Metastasis (2 papers), Monoclonal and Polyclonal Antibodies Research (2 papers), Drug Transport and Resistance Mechanisms (2 papers), Pharmacogenetics and Drug Metabolism (1 paper), NF-κB Signaling Pathways (1 paper), Cytokine Signaling Pathways and Interactions (1 paper) and Immunotherapy and Immune Responses (1 paper). The work is most often cited by research in Molecular Biology (1.8k citations), Oncology (537 citations), Immunology (436 citations), Cancer Research (258 citations) and Orthopedics and Sports Medicine (109 citations). Mark E. Tometsko has collaborated with scholars based in United States, Japan and Spain. Frequent co-authors include William C. Dougall, David J. Cosman, Dirk M. Anderson, Laurent Galibert, Eileen R. Roux, Eugene Maraskovsky, Robert F. DuBose, Mark Teepe, Allison P. Armstrong and Claire L. Sutherland. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Clinical & Experimental Metastasis, Molecular Pharmaceutics and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.